Scientists have obtained stem cells from pigs, sheep, and cattle without the need for serum, feeder cells, or antibiotics to pave the way for “manufacturing cell-cultured meat and breeding enhanced livestock”.
The researchers for the study were mainly from the University of Nottingham’s School of Biosciences in the UK, in collaboration with the Universities of Cambridge, Exeter, Tokyo, and Meijit.
According to the lead researcher, Ramiro Alberio, the ability to derive and maintain livestock stem cells under chemically defined conditions allows the development of novel food products, such as cultured meat.
He added that the newly-developed cell lines are a step-change from previous models for their unique ability to permanently grow to make muscle and fat.”
The stem cell lines can develop into multiple cell types, which can then be genetically manipulated through the Crispr/Cas9 gene-editing tool.
The results could broaden research into gene editing animals to improve productivity, adaptation to climate change, diet modifications, and the environmental impact of livestock production.
Alberio added the results allow gene editing to happen naturally over a long time selectively and rapidly to customize specific traits. This can accelerate the pace of genetic selection of livestock and cultured meat to improve productivity and the creation of healthier foods.
The research offers potential solutions that the food industry could use at scale amid a growing population to feed in a changing climate.
According to the study, the new chemically defined approach provides greater consistency and safety than the use of serum, making it an ideal solution for manufacturing new lab-grown food products.”.
It added that the use of serum has technical disadvantages, including its undefined nature, batch-to-batch variability in composition, and the risk of contamination.
The research, titled “Pluripotent stem cells related to embryonic disc exhibit common self-renewal requirements in diverse livestock species,” was published in the Development journal.
It was funded by BBSRC, EU (ERC), MRC and Wellcome Trust.


SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
Tabletop particle accelerator could transform medicine and materials science
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Singapore Budget 2026 Set for Fiscal Prudence as Growth Remains Resilient
China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
NASA Partners with Katalyst to Save Swift Observatory with Innovative Docking Mission
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission
Neuralink Expands Brain Implant Trials with 12 Global Patients
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
South Korea’s Weak Won Struggles as Retail Investors Pour Money Into U.S. Stocks 



